Immunomedics Inc (NASDAQ:IMMU)

15.44
Delayed Data
As of Oct 18
 -0.42 / -2.65%
Today’s Change
11.55
Today|||52-Week Range
24.99
+8.20%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$2.7B

Company Description

Immunomedics, Inc. is a clinical-stage biopharmaceutical company, which engages in the business of researching, developing, manufacturing and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. It operates through the United States, and Europe geographical segments. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ.

Contact Information

Immunomedics, Inc.
300 The American Road
Morris Plains New Jersey 07950
P:(973) 605-8200
Investor Relations:
19736058200123

Employees

Shareholders

Other institutional46.93%
Mutual fund holders43.18%
Individual stakeholders24.56%

Top Executives

There are no executives to display.